Clinical Trial Update: A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical study of TQA3605 tablets as monotherapy or in combination with nucleoside analogues for treatment-naive and previously treated patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TQA3605

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Chronic Hepatitis b | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING